End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.56 EGP | -5.19% | -3.76% | -18.47% |
Mar. 03 | Ibnsina Pharma Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 05 | Ibnsina Pharma(CASE:ISPH) added to EGX 30 Index | CI |
Sales 2024 * | 37.57B 794M | Sales 2025 * | 44.09B 931M | Capitalization | 2.58B 54.5M |
---|---|---|---|---|---|
Net income 2024 * | 316M 6.67M | Net income 2025 * | 417M 8.81M | EV / Sales 2024 * | 0.17 x |
Net Debt 2024 * | 3.72B 78.56M | Net Debt 2025 * | 3.56B 75.22M | EV / Sales 2025 * | 0.14 x |
P/E ratio 2024 * |
8.53
x | P/E ratio 2025 * |
6.65
x | Employees | 5,500 |
Yield 2024 * |
1.52% | Yield 2025 * |
3.02% | Free-Float | 60.26% |
1 day | -5.19% | ||
1 week | -3.76% | ||
Current month | -32.63% | ||
1 month | -28.89% | ||
3 months | -18.99% | ||
6 months | +28.64% | ||
Current year | -18.47% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 | |
Momen Gomaa
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | - | - | |
Chief Executive Officer | - | 00-12-17 | |
Chief Executive Officer | - | 00-12-17 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 2.56 | -5.19% | 9,369,508 |
24-03-27 | 2.7 | -2.53% | 10,467,700 |
24-03-26 | 2.77 | -2.12% | 16,162,580 |
24-03-25 | 2.83 | +5.20% | 14,811,050 |
24-03-24 | 2.69 | +1.13% | 14,637,520 |
End-of-day quote Egyptian Exchange, March 27, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.47% | 54.44M | |
-16.93% | 18.7B | |
-29.16% | 11.29B | |
-2.30% | 6.68B | |
-1.85% | 5.5B | |
+8.03% | 5.13B | |
+34.14% | 3.9B | |
-9.09% | 3.76B | |
+3.99% | 3.51B | |
-15.22% | 3.33B |